PGHL

Procter & Gamble Health Share Price Procter & Gamble Health

₹4,709.9
-28.9 (-0.61%)
29 March, 2024 01:36 BSE: 500126 NSE: PGHLISIN: INE199A01012

Start SIP in Procter & Gamble Health

Start SIP

Procter & Gamble Health Performance

Day Range

  • Low 4,698
  • High 4,785
₹ 4,709

52 Week Range

  • Low 4,493
  • High 5,643
₹ 4,709
  • Open Price4,739
  • Previous Close4,739
  • Volume72052

Procter & Gamble Health Share Price

  • Over 1 Month -7.45%
  • Over 3 Month -4.63%
  • Over 6 Month -7.83%
  • Over 1 Year -2.78%

Procter & Gamble Health Key Statistics

P/E Ratio 34.5
PEG Ratio -13
Market Cap Cr 7,818
Price to Book Ratio 10.4
EPS 137.9
Dividend 5.3
Relative Strength Index 28.6
Money Flow Index 12.31
MACD Signal -79
Average True Range 107.68
Procter & Gamble Health Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 310305301321
Operating Expenses Qtr Cr 208216256243
Operating Profit Qtr Cr 102894580
Depreciation Qtr Cr 7666
Interest Qtr Cr 0000
Tax Qtr Cr 28221419
Net Profit Qtr Cr 72663059
IndicatorJun 2023
Total Revenue Annual Cr 1,248
Operating Expenses Annual Cr 905
Operating Profit Annual in Cr 325
Depreciation Cr 28
Interest Annual Cr 1
Tax Annual Cr 85
Net Profit Annual Cr 229
IndicatorJun 2023
Cash from Operating Activity Annual Cr 236
Cash from Investing Activity Annual Cr -22
Cash from Financing Annual Activity Cr -98
Net Cash Flow Annual Cr 116
IndicatorJun 2023
Total ShareHolders Funds Annual Cr 751
Fixed Assets Annual Cr 176
Total Non Current Assets Annual Cr 305
Total Current Assets Annual Cr 796
Total Assets Annual Cr 1,101
IndicatorJun 2023
Book Value Per Share Annual Rs 452
ROE Annual % 31
ROCE Annual % 40
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 28
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorJun 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorJun 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorJun 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorJun 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹4,709.9
-28.9 (-0.61%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹4,923.01
  • 50 Day
  • ₹5,030.20
  • 100 Day
  • ₹5,065.04
  • 200 Day
  • ₹5,025.64
  • 20 Day
  • ₹4,958.28
  • 50 Day
  • ₹5,110.22
  • 100 Day
  • ₹5,092.06
  • 200 Day
  • ₹5,107.35

Procter & Gamble Health Resistance and Support

PIVOT
₹4,731.
Resistance
First Resistance 4,763.90
Second Resistance 4,817.90
Third Resistance 4,850.80
RSI 28.60
MFI 12.31
MACD Single Line -79.00
MACD -100.27
Support
First Resistance 4,677.00
Second Resistance 4,644.10
Third Resistance 4,590.10

Procter & Gamble Health Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 73,024 6,691,189 91.63
Week 60,310 5,371,812 89.07
1 Month 25,233 2,147,040 85.09
6 Month 16,453 1,194,679 72.61

Procter & Gamble Health Result Highlights

Procter & Gamble Health Synopsis

NSE-Medical-Generic Drugs

P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1229.62 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2023. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
Market Cap 7,811
Sales 1,237
Shares in Float 0.80
No of funds 136
Yield 2.11
Book Value 10.48
U/D Vol ratio 0.7
LTDebt / Equity
Alpha -0.03
Beta 0.19

Procter & Gamble Health

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 51.82%51.82%51.82%51.82%
Mutual Funds 8.98%8.41%8.1%7.34%
Insurance Companies 3.41%3.71%4.08%4.87%
Foreign Portfolio Investors 7.6%7.38%7.15%6.72%
Financial Institutions/ Banks
Individual Investors 22.9%23.44%23.64%24.09%
Others 5.29%5.24%5.21%5.16%

Procter & Gamble Health Management

Name Designation
Mr. Suresh Talwar Chairman & Ind.Director
Mr. Milind Thatte Managing Director
Mr. Lokesh Chandak Executive Director & CFO
Ms. Seema Sambasivan Non Executive Director
Mr. Aalok Agrawal Non Executive Director
Mrs. Rani Jadhav Independent Director
Mr. S Madhavan Independent Director

Procter & Gamble Health Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Procter & Gamble Health Corporate Action

Date Purpose Remarks
2024-02-06 Quarterly Results & Interim Dividend
2023-11-03 Quarterly Results
2023-08-23 Audited Results & Final Dividend
2023-05-15 Quarterly Results
2023-02-05 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-02-14 INTERIM Rs.50.00 per share(500%)Interim Dividend
2024-02-14 SPECIAL Rs.150.00 per share(1500%)Special Dividend
2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

Procter & Gamble Health FAQs

What is Share Price of Procter & Gamble Health ?

Procter & Gamble Health share price is ₹4,709 As on 29 March, 2024 | 01:22

What is the Market Cap of Procter & Gamble Health ?

The Market Cap of Procter & Gamble Health is ₹7818.2 Cr As on 29 March, 2024 | 01:22

What is the P/E ratio of Procter & Gamble Health ?

The P/E ratio of Procter & Gamble Health is 34.5 As on 29 March, 2024 | 01:22

What is the PB ratio of Procter & Gamble Health ?

The PB ratio of Procter & Gamble Health is 10.4 As on 29 March, 2024 | 01:22

Q2FY23